raia drogasil s.a. - RADLY

RADLY

Close Chg Chg %
4.82 -0.66 -13.69%

Open Market

4.16

-0.66 (13.69%)

Volume: 266.00

Last Updated:

Apr 7, 2026, 12:40 PM EDT

Company Overview: raia drogasil s.a. - RADLY

RADLY Key Data

Open

$4.70

Day Range

4.16 - 4.70

52 Week Range

2.21 - 5.34

Market Cap

$7.37B

Shares Outstanding

1.75B

Public Float

N/A

Beta

0.80

Rev. Per Employee

N/A

P/E Ratio

29.98

EPS

$0.13

Yield

113.91%

Dividend

$0.01

EX-DIVIDEND DATE

Apr 13, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

10.71K

 

RADLY Performance

1 Week
 
13.44%
 
1 Month
 
4.33%
 
3 Months
 
4.78%
 
1 Year
 
29.85%
 
5 Years
 
N/A
 

RADLY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About raia drogasil s.a. - RADLY

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its stores are supplied by distribution centers located in the states of São Paulo, Rio de Janeiro, Minas Gerais, Paraná, Goiás, Pernambuco, and Bahia. The company was founded in 1905 and is headquartered in Butanta, Brazil.

RADLY At a Glance

Raia Drogasil SA
Avenue Corifeu de Azevedo Marques
Butanta, Sao Paulo 05339-000
Phone 55-11-3769-5678 Revenue 7.92B
Industry Drugstore Chains Net Income 232.13M
Sector Retail Trade 2025 Sales Growth 9.848%
Fiscal Year-end 12 / 2026 Employees 73,895
View SEC Filings

RADLY Valuation

P/E Current 29.979
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 30.369
Price to Sales Ratio 0.896
Price to Book Ratio 5.595
Price to Cash Flow Ratio 16.31
Enterprise Value to EBITDA 10.349
Enterprise Value to Sales 1.088
Total Debt to Enterprise Value 0.187

RADLY Efficiency

Revenue/Employee 107,187.478
Income Per Employee 3,141.375
Receivables Turnover 9.277
Total Asset Turnover 1.912

RADLY Liquidity

Current Ratio 1.462
Quick Ratio 0.523
Cash Ratio 0.052

RADLY Profitability

Gross Margin 24.75
Operating Margin 5.96
Pretax Margin 3.268
Net Margin 2.931
Return on Assets 5.603
Return on Equity 19.527
Return on Total Capital 7.873
Return on Invested Capital 9.872

RADLY Capital Structure

Total Debt to Total Equity 120.649
Total Debt to Total Capital 54.679
Total Debt to Total Assets 34.679
Long-Term Debt to Equity 99.763
Long-Term Debt to Total Capital 45.214
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Raia Drogasil S.a. - RADLY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
5.63B 6.80B 7.21B 7.92B
Sales Growth
+25.88% +20.85% +6.01% +9.85%
Cost of Goods Sold (COGS) incl D&A
4.21B 5.09B 5.40B 5.96B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
285.28M 332.61M 334.19M 360.33M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+24.67% +20.98% +6.09% +10.36%
Gross Income
1.42B 1.71B 1.81B 1.96B
Gross Income Growth
+29.61% +20.45% +5.76% +8.33%
Gross Profit Margin
+25.24% +25.15% +25.10% +24.75%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.08B 1.31B 1.37B 1.48B
Research & Development
- - - -
-
Other SG&A
1.08B 1.31B 1.37B 1.48B
SGA Growth
+27.16% +20.97% +4.93% +7.97%
Other Operating Expense
(20.65M) (32.78M) (20.67M) 6.75M
Unusual Expense
5.49M 12.03M 20.19M (8.44M)
EBIT after Unusual Expense
354.71M 424.08M 437.94M 480.53M
Non Operating Income/Expense
(19.72M) (37.14M) (28.20M) (29.57M)
Non-Operating Interest Income
5.48M 10.58M 6.69M 3.47M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
103.79M 140.84M 146.72M 192.12M
Interest Expense Growth
+76.42% +35.69% +4.17% +30.95%
Gross Interest Expense
103.79M 140.84M 146.72M 192.12M
Interest Capitalized
- - - -
-
Pretax Income
231.20M 246.09M 263.02M 258.84M
Pretax Income Growth
+26.22% +6.44% +6.88% -1.59%
Pretax Margin
+4.11% +3.62% +3.65% +3.27%
Income Tax
34.51M 25.94M 38.51M 26.46M
Income Tax - Current - Domestic
40.82M 62.97M 60.89M 37.01M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(6.31M) (37.03M) (22.37M) (10.55M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
196.53M 217.65M 224.70M 232.74M
Minority Interest Expense
3.65M 6.44M 2.13M 605.36K
Net Income
192.88M 211.21M 222.57M 232.13M
Net Income Growth
+38.42% +9.51% +5.38% +4.30%
Net Margin Growth
+3.43% +3.11% +3.09% +2.93%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
192.88M 211.21M 222.57M 232.13M
Preferred Dividends
- - - -
-
Net Income Available to Common
192.88M 211.21M 222.57M 232.13M
EPS (Basic)
0.1104 0.1222 0.1323 0.1409
EPS (Basic) Growth
+38.69% +10.69% +8.27% +6.50%
Basic Shares Outstanding
1.75B 1.73B 1.68B 1.65B
EPS (Diluted)
0.1099 0.1222 0.1318 0.14
EPS (Diluted) Growth
+38.41% +11.19% +7.86% +6.22%
Diluted Shares Outstanding
1.75B 1.73B 1.69B 1.66B
EBITDA
645.48M 768.72M 792.33M 832.41M
EBITDA Growth
+29.27% +19.09% +3.07% +5.06%
EBITDA Margin
+11.47% +11.30% +10.99% +10.51%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 5.439
Number of Ratings 12 Current Quarters Estimate 0.052
FY Report Date 06 / 2026 Current Year's Estimate 0.192
Last Quarter’s Earnings 0.035 Median PE on CY Estimate N/A
Year Ago Earnings 0.15 Next Fiscal Year Estimate 0.241
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 9 8
Mean Estimate 0.05 0.05 0.19 0.24
High Estimates 0.06 0.05 0.20 0.26
Low Estimate 0.05 0.05 0.18 0.23
Coefficient of Variance 6.42 1.30 3.56 4.18

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 10 11
OVERWEIGHT 0 0 0
HOLD 3 3 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Buy Buy

Raia Drogasil S.A. in the News